Completed
Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery
NCT04521140
- Conditions
- Anterior Chamber Inflammation, Corneal Defect, Corneal Diseases, +12 more
- Locations
-
- Advanced Vision Care Los Angeles, California, United States